I don't expect anything tomorrow, I do expect at the end of this quarter or beginning of the next that ESS will have brought in something of value.

The rest of the pipeline is a money pit currently, they are millions of dollars away from producing something significant.

In the short term I belive that ESS can do what Lympro never could and actually bring significant value to shareholders.